ALB•Albemarle cut its fiscal 2026 capital expenditure guidance to $300 million-$350 million from about $500 million, citing project resequencing and capital efficiency improvements. Year-to-date free cash flow reached $1.2 billion.
Albemarle lowered its fiscal 2026 capital expenditure guidance to $300 million-$350 million from about $500 million, reflecting project resequencing and capital efficiency improvements. Sustaining capital spending is expected to be below $300 million, while future growth spending will vary as projects progress.
Year-to-date free cash flow reached $1.2 billion, supported by more than $150 million in annualized cost and productivity improvements.
